Alyeska Investment Group, L.P. Astrazeneca PLC Transaction History
Alyeska Investment Group, L.P.
- $15.5 Billion
- Q1 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 2,795,681 shares of AZN stock, worth $218 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
2,795,681
Previous 574,997
386.21%
Holding current value
$218 Million
Previous $38.7 Million
389.1%
% of portfolio
1.23%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...